‌

US Patent 7094427 Combination immediate release controlled release levodopa/carbidopa dosage forms

Patent 7094427 was granted and assigned to Impax Laboratories on August, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Current Assignee

Impax Laboratories

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

August 22, 2006

Patent Application Number

10241837

Date Filed

September 12, 2002

Patent Citations Received

US Patent 12128141 Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof

0

0

US Patent 12064521 Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

0

US Patent 12109185 Levodopa dosing regimen

0

US Patent 11666536 Extended release compositions comprising pyridostigmine

0

US Patent 11666538 Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

0

US Patent 11752107 5-hydroxytryptophan gastroretentive dosage forms

US Patent 11779567 Method for optimizing 5-hydroxytryptamine function in the brain for therapeutic purposes

...

Patent Primary Examiner

Humera N. Sheikh

Patent abstract

The present invention relates to dosage forms of a combination of carbidopa and levodopa comprising both immediate release and controlled release components for the treatment of ailments associated with depleted amounts of dopamine in a patient's brain tissue.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7094427 Combination immediate release controlled release levodopa/carbidopa dosage forms

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.